LAUSR

Dupilumab: Advances in the off‐label usage of IL4/IL13 antagonist in dermatoses

Sign Up to like & get
recommendations!
2 Published in 2022 at "Dermatologic Therapy"

DOI: 10.1111/dth.15924

Abstract: Type 2 immune response refers to a complicated series of immune responses characterized by Th2 polarization and Th2 cytokines secretion. The IgE secretion, airway hypersensitivity, and effector cell recruitment (eosinophils, mast cells, basophils) in skin… read more here.

Keywords: dupilumab advances; type immune; immune response; type ... See more keywords